Jaemoon Koh

Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers

Moon‐Young Kim, Jaemoon Koh, Sehui Kim et al. · Lung Cancer · 2015 · 186 citations

Cancer Immunosurveillance, Advanced Lung Disease, Oncogenic Agent +12

Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status

Su‐Jin Shin, Yoon Kyung Jeon, Pil-Jong Kim et al. · Annals of Surgical Oncology · 2015 · 185 citations

Urology, Genitourinary Cancer, Oncogenic Agent +9

Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas

Sehui Kim, Moon‐Young Kim, Jaemoon Koh et al. · European Journal of Cancer · 2015 · 180 citations

Tumor Biology, Medicine, Pathology +11

PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung

Sehui Kim, Jaemoon Koh, Moon‐Young Kim et al. · Human Pathology · 2016 · 164 citations

Tumor Biology, Epithelial-to-mesenchymal Transition, Pd-l1 Expression +10

Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status

Jaemoon Koh, Heounjeong Go, Bhumsuk Keam et al. · Modern Pathology · 2015 · 159 citations · Full text

Pulmonary Adenocarcinoma, Cell Death-ligand 1, Oncogenic Agent +10